Shopping Cart 0
Cart Subtotal
AED 0

Global Fragment-Based Drug Discovery Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 12478

Access to Printed Report; No Soft Copy
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
AED 22754

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 22754

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 22754

Details

The Fragment-Based Drug Discovery market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Fragment-Based Drug Discovery market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Fragment-Based Drug Discovery market. The report focuses on well-known providers in the global Fragment-Based Drug Discovery industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Fragment-Based Drug Discovery Industry will develop is also analyzed in detail in Chapter 1.7 of the report.

In Chapter 2.4, we analyzed industry trends in the context of COVID-19.

In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.

In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.

In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Fragment-Based Drug Discovery market covered in Chapter 4:

Sygnature Discovery

Crown Bioscience, Inc

Alveus Pharmaceuticals Pvt. Ltd

Proteros Fragments GmbH

Emerald BioStructures, Inc

Structure Based Design, Inc

Charles River Laboratories International, Inc

Evotec AG

Sprint Bioscience

Kinetic Discovery Limited

Astex Pharmaceuticals

Beactica AB

In Chapter 11 and 13.3, on the basis of types, the Fragment-Based Drug Discovery market from 2015 to 2026 is primarily split into:

NMR Spectroscopy

DSF Assay

Fluorescence Polarization (FP)

Isothermal Titration Calorimetry (ITC)

X-ray Crystallography

In Chapter 12 and 13.4, on the basis of applications, the Fragment-Based Drug Discovery market from 2015 to 2026 covers:

Biopharmaceutical Companies

CROs

Academic and Research Institutions

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:

North America (Covered in Chapter 6 and 13)

United States

Canada

Mexico

Europe (Covered in Chapter 7 and 13)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 8 and 13)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 9 and 13)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 10 and 13)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2026

READ MORE

Table Of Content

Scope

Table of Content

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Regulatory Scenario by Region/Country

1.4 Market Investment Scenario Strategic

1.5 Market Analysis by Type

1.5.1 Global Fragment-Based Drug Discovery Market Share by Type (2020-2026)

1.5.2 NMR Spectroscopy

1.5.3 DSF Assay

1.5.4 Fluorescence Polarization (FP)

1.5.5 Isothermal Titration Calorimetry (ITC)

1.5.6 X-ray Crystallography

1.6 Market by Application

1.6.1 Global Fragment-Based Drug Discovery Market Share by Application (2020-2026)

1.6.2 Biopharmaceutical Companies

1.6.3 CROs

1.6.4 Academic and Research Institutions

1.7 Fragment-Based Drug Discovery Industry Development Trends under COVID-19 Outbreak

1.7.1 Global COVID-19 Status Overview

1.7.2 Influence of COVID-19 Outbreak on Fragment-Based Drug Discovery Industry Development

2. Global Market Growth Trends

2.1 Industry Trends

2.1.1 SWOT Analysis

2.1.2 PorteraEURs Five Forces Analysis

2.2 Potential Market and Growth Potential Analysis

2.3 Industry News and Policies by Regions

2.3.1 Industry News

2.3.2 Industry Policies

2.4 Industry Trends Under COVID-19

3 Value Chain of Fragment-Based Drug Discovery Market

3.1 Value Chain Status

3.2 Fragment-Based Drug Discovery Manufacturing Cost Structure Analysis

3.2.1 Production Process Analysis

3.2.2 Manufacturing Cost Structure of Fragment-Based Drug Discovery

3.2.3 Labor Cost of Fragment-Based Drug Discovery

3.2.3.1 Labor Cost of Fragment-Based Drug Discovery Under COVID-19

3.3 Sales and Marketing Model Analysis

3.4 Downstream Major Customer Analysis (by Region)

3.5 Value Chain Status Under COVID-19

4 Players Profiles

4.1 Sygnature Discovery

4.1.1 Sygnature Discovery Basic Information

4.1.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification

4.1.3 Sygnature Discovery Fragment-Based Drug Discovery Market Performance (2015-2020)

4.1.4 Sygnature Discovery Business Overview

4.2 Crown Bioscience, Inc

4.2.1 Crown Bioscience, Inc Basic Information

4.2.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification

4.2.3 Crown Bioscience, Inc Fragment-Based Drug Discovery Market Performance (2015-2020)

4.2.4 Crown Bioscience, Inc Business Overview

4.3 Alveus Pharmaceuticals Pvt. Ltd

4.3.1 Alveus Pharmaceuticals Pvt. Ltd Basic Information

4.3.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification

4.3.3 Alveus Pharmaceuticals Pvt. Ltd Fragment-Based Drug Discovery Market Performance (2015-2020)

4.3.4 Alveus Pharmaceuticals Pvt. Ltd Business Overview

4.4 Proteros Fragments GmbH

4.4.1 Proteros Fragments GmbH Basic Information

4.4.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification

4.4.3 Proteros Fragments GmbH Fragment-Based Drug Discovery Market Performance (2015-2020)

4.4.4 Proteros Fragments GmbH Business Overview

4.5 Emerald BioStructures, Inc

4.5.1 Emerald BioStructures, Inc Basic Information

4.5.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification

4.5.3 Emerald BioStructures, Inc Fragment-Based Drug Discovery Market Performance (2015-2020)

4.5.4 Emerald BioStructures, Inc Business Overview

4.6 Structure Based Design, Inc

4.6.1 Structure Based Design, Inc Basic Information

4.6.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification

4.6.3 Structure Based Design, Inc Fragment-Based Drug Discovery Market Performance (2015-2020)

4.6.4 Structure Based Design, Inc Business Overview

4.7 Charles River Laboratories International, Inc

4.7.1 Charles River Laboratories International, Inc Basic Information

4.7.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification

4.7.3 Charles River Laboratories International, Inc Fragment-Based Drug Discovery Market Performance (2015-2020)

4.7.4 Charles River Laboratories International, Inc Business Overview

4.8 Evotec AG

4.8.1 Evotec AG Basic Information

4.8.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification

4.8.3 Evotec AG Fragment-Based Drug Discovery Market Performance (2015-2020)

4.8.4 Evotec AG Business Overview

4.9 Sprint Bioscience

4.9.1 Sprint Bioscience Basic Information

4.9.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification

4.9.3 Sprint Bioscience Fragment-Based Drug Discovery Market Performance (2015-2020)

4.9.4 Sprint Bioscience Business Overview

4.10 Kinetic Discovery Limited

4.10.1 Kinetic Discovery Limited Basic Information

4.10.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification

4.10.3 Kinetic Discovery Limited Fragment-Based Drug Discovery Market Performance (2015-2020)

4.10.4 Kinetic Discovery Limited Business Overview

4.11 Astex Pharmaceuticals

4.11.1 Astex Pharmaceuticals Basic Information

4.11.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification

4.11.3 Astex Pharmaceuticals Fragment-Based Drug Discovery Market Performance (2015-2020)

4.11.4 Astex Pharmaceuticals Business Overview

4.12 Beactica AB

4.12.1 Beactica AB Basic Information

4.12.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification

4.12.3 Beactica AB Fragment-Based Drug Discovery Market Performance (2015-2020)

4.12.4 Beactica AB Business Overview

5 Global Fragment-Based Drug Discovery Market Analysis by Regions

5.1 Global Fragment-Based Drug Discovery Sales, Revenue and Market Share by Regions

5.1.1 Global Fragment-Based Drug Discovery Sales by Regions (2015-2020)

5.1.2 Global Fragment-Based Drug Discovery Revenue by Regions (2015-2020)

5.2 North America Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

5.3 Europe Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

5.4 Asia-Pacific Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

5.5 Middle East and Africa Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

5.6 South America Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

6 North America Fragment-Based Drug Discovery Market Analysis by Countries

6.1 North America Fragment-Based Drug Discovery Sales, Revenue and Market Share by Countries

6.1.1 North America Fragment-Based Drug Discovery Sales by Countries (2015-2020)

6.1.2 North America Fragment-Based Drug Discovery Revenue by Countries (2015-2020)

6.1.3 North America Fragment-Based Drug Discovery Market Under COVID-19

6.2 United States Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

6.2.1 United States Fragment-Based Drug Discovery Market Under COVID-19

6.3 Canada Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

6.4 Mexico Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

7 Europe Fragment-Based Drug Discovery Market Analysis by Countries

7.1 Europe Fragment-Based Drug Discovery Sales, Revenue and Market Share by Countries

7.1.1 Europe Fragment-Based Drug Discovery Sales by Countries (2015-2020)

7.1.2 Europe Fragment-Based Drug Discovery Revenue by Countries (2015-2020)

7.1.3 Europe Fragment-Based Drug Discovery Market Under COVID-19

7.2 Germany Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

7.2.1 Germany Fragment-Based Drug Discovery Market Under COVID-19

7.3 UK Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

7.3.1 UK Fragment-Based Drug Discovery Market Under COVID-19

7.4 France Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

7.4.1 France Fragment-Based Drug Discovery Market Under COVID-19

7.5 Italy Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

7.5.1 Italy Fragment-Based Drug Discovery Market Under COVID-19

7.6 Spain Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

7.6.1 Spain Fragment-Based Drug Discovery Market Under COVID-19

7.7 Russia Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

7.7.1 Russia Fragment-Based Drug Discovery Market Under COVID-19

8 Asia-Pacific Fragment-Based Drug Discovery Market Analysis by Countries

8.1 Asia-Pacific Fragment-Based Drug Discovery Sales, Revenue and Market Share by Countries

8.1.1 Asia-Pacific Fragment-Based Drug Discovery Sales by Countries (2015-2020)

8.1.2 Asia-Pacific Fragment-Based Drug Discovery Revenue by Countries (2015-2020)

8.1.3 Asia-Pacific Fragment-Based Drug Discovery Market Under COVID-19

8.2 China Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

8.2.1 China Fragment-Based Drug Discovery Market Under COVID-19

8.3 Japan Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

8.3.1 Japan Fragment-Based Drug Discovery Market Under COVID-19

8.4 South Korea Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

8.4.1 South Korea Fragment-Based Drug Discovery Market Under COVID-19

8.5 Australia Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

8.6 India Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

8.6.1 India Fragment-Based Drug Discovery Market Under COVID-19

8.7 Southeast Asia Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

8.7.1 Southeast Asia Fragment-Based Drug Discovery Market Under COVID-19

9 Middle East and Africa Fragment-Based Drug Discovery Market Analysis by Countries

9.1 Middle East and Africa Fragment-Based Drug Discovery Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Fragment-Based Drug Discovery Sales by Countries (2015-2020)

9.1.2 Middle East and Africa Fragment-Based Drug Discovery Revenue by Countries (2015-2020)

9.1.3 Middle East and Africa Fragment-Based Drug Discovery Market Under COVID-19

9.2 Saudi Arabia Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

9.3 UAE Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

9.4 Egypt Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

9.5 Nigeria Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

9.6 South Africa Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

10 South America Fragment-Based Drug Discovery Market Analysis by Countries

10.1 South America Fragment-Based Drug Discovery Sales, Revenue and Market Share by Countries

10.1.1 South America Fragment-Based Drug Discovery Sales by Countries (2015-2020)

10.1.2 South America Fragment-Based Drug Discovery Revenue by Countries (2015-2020)

10.1.3 South America Fragment-Based Drug Discovery Market Under COVID-19

10.2 Brazil Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

10.2.1 Brazil Fragment-Based Drug Discovery Market Under COVID-19

10.3 Argentina Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

10.4 Columbia Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

10.5 Chile Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

11 Global Fragment-Based Drug Discovery Market Segment by Types

11.1 Global Fragment-Based Drug Discovery Sales, Revenue and Market Share by Types (2015-2020)

11.1.1 Global Fragment-Based Drug Discovery Sales and Market Share by Types (2015-2020)

11.1.2 Global Fragment-Based Drug Discovery Revenue and Market Share by Types (2015-2020)

11.2 NMR Spectroscopy Sales and Price (2015-2020)

11.3 DSF Assay Sales and Price (2015-2020)

11.4 Fluorescence Polarization (FP) Sales and Price (2015-2020)

11.5 Isothermal Titration Calorimetry (ITC) Sales and Price (2015-2020)

11.6 X-ray Crystallography Sales and Price (2015-2020)

12 Global Fragment-Based Drug Discovery Market Segment by Applications

12.1 Global Fragment-Based Drug Discovery Sales, Revenue and Market Share by Applications (2015-2020)

12.1.1 Global Fragment-Based Drug Discovery Sales and Market Share by Applications (2015-2020)

12.1.2 Global Fragment-Based Drug Discovery Revenue and Market Share by Applications (2015-2020)

12.2 Biopharmaceutical Companies Sales, Revenue and Growth Rate (2015-2020)

12.3 CROs Sales, Revenue and Growth Rate (2015-2020)

12.4 Academic and Research Institutions Sales, Revenue and Growth Rate (2015-2020)

13 Fragment-Based Drug Discovery Market Forecast by Regions (2020-2026)

13.1 Global Fragment-Based Drug Discovery Sales, Revenue and Growth Rate (2020-2026)

13.2 Fragment-Based Drug Discovery Market Forecast by Regions (2020-2026)

13.2.1 North America Fragment-Based Drug Discovery Market Forecast (2020-2026)

13.2.2 Europe Fragment-Based Drug Discovery Market Forecast (2020-2026)

13.2.3 Asia-Pacific Fragment-Based Drug Discovery Market Forecast (2020-2026)

13.2.4 Middle East and Africa Fragment-Based Drug Discovery Market Forecast (2020-2026)

13.2.5 South America Fragment-Based Drug Discovery Market Forecast (2020-2026)

13.3 Fragment-Based Drug Discovery Market Forecast by Types (2020-2026)

13.4 Fragment-Based Drug Discovery Market Forecast by Applications (2020-2026)

13.5 Fragment-Based Drug Discovery Market Forecast Under COVID-19

14 Appendix

14.1 Methodology

14.2 Research Data Source


List Of Figure

List of Tables and Figures

Table Global Fragment-Based Drug Discovery Market Size Growth Rate by Type (2020-2026)

Figure Global Fragment-Based Drug Discovery Market Share by Type in 2019 & 2026

Figure NMR Spectroscopy Features

Figure DSF Assay Features

Figure Fluorescence Polarization (FP) Features

Figure Isothermal Titration Calorimetry (ITC) Features

Figure X-ray Crystallography Features

Table Global Fragment-Based Drug Discovery Market Size Growth by Application (2020-2026)

Figure Global Fragment-Based Drug Discovery Market Share by Application in 2019 & 2026

Figure Biopharmaceutical Companies Description

Figure CROs Description

Figure Academic and Research Institutions Description

Figure Global COVID-19 Status Overview

Table Influence of COVID-19 Outbreak on Fragment-Based Drug Discovery Industry Development

Table SWOT Analysis

Figure Porter's Five Forces Analysis

Figure Global Fragment-Based Drug Discovery Market Size and Growth Rate 2015-2026

Table Industry News

Table Industry Policies

Figure Value Chain Status of Fragment-Based Drug Discovery

Figure Production Process of Fragment-Based Drug Discovery

Figure Manufacturing Cost Structure of Fragment-Based Drug Discovery

Figure Major Company Analysis (by Business Distribution Base, by Product Type)

Table Downstream Major Customer Analysis (by Region)

Table Sygnature Discovery Profile

Table Sygnature Discovery Production, Value, Price, Gross Margin 2015-2020

Table Crown Bioscience, Inc Profile

Table Crown Bioscience, Inc Production, Value, Price, Gross Margin 2015-2020

Table Alveus Pharmaceuticals Pvt. Ltd Profile

Table Alveus Pharmaceuticals Pvt. Ltd Production, Value, Price, Gross Margin 2015-2020

Table Proteros Fragments GmbH Profile

Table Proteros Fragments GmbH Production, Value, Price, Gross Margin 2015-2020

Table Emerald BioStructures, Inc Profile

Table Emerald BioStructures, Inc Production, Value, Price, Gross Margin 2015-2020

Table Structure Based Design, Inc Profile

Table Structure Based Design, Inc Production, Value, Price, Gross Margin 2015-2020

Table Charles River Laboratories International, Inc Profile

Table Charles River Laboratories International, Inc Production, Value, Price, Gross Margin 2015-2020

Table Evotec AG Profile

Table Evotec AG Production, Value, Price, Gross Margin 2015-2020

Table Sprint Bioscience Profile

Table Sprint Bioscience Production, Value, Price, Gross Margin 2015-2020

Table Kinetic Discovery Limited Profile

Table Kinetic Discovery Limited Production, Value, Price, Gross Margin 2015-2020

Table Astex Pharmaceuticals Profile

Table Astex Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020

Table Beactica AB Profile

Table Beactica AB Production, Value, Price, Gross Margin 2015-2020

Figure Global Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Global Fragment-Based Drug Discovery Revenue (USD ) and Growth (2015-2020)

Table Global Fragment-Based Drug Discovery Sales by Regions (2015-2020)

Table Global Fragment-Based Drug Discovery Sales Market Share by Regions (2015-2020)

Table Global Fragment-Based Drug Discovery Revenue (USD ) by Regions (2015-2020)

Table Global Fragment-Based Drug Discovery Revenue Market Share by Regions (2015-2020)

Table Global Fragment-Based Drug Discovery Revenue Market Share by Regions in 2015

Table Global Fragment-Based Drug Discovery Revenue Market Share by Regions in 2019

Figure North America Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Europe Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure South America Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure North America Fragment-Based Drug Discovery Revenue (USD ) and Growth (2015-2020)

Table North America Fragment-Based Drug Discovery Sales by Countries (2015-2020)

Table North America Fragment-Based Drug Discovery Sales Market Share by Countries (2015-2020)

Figure North America Fragment-Based Drug Discovery Sales Market Share by Countries in 2015

Figure North America Fragment-Based Drug Discovery Sales Market Share by Countries in 2019

Table North America Fragment-Based Drug Discovery Revenue (USD ) by Countries (2015-2020)

Table North America Fragment-Based Drug Discovery Revenue Market Share by Countries (2015-2020)

Figure North America Fragment-Based Drug Discovery Revenue Market Share by Countries in 2015

Figure North America Fragment-Based Drug Discovery Revenue Market Share by Countries in 2019

Figure United States Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Canada Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Mexico Fragment-Based Drug Discovery Sales and Growth (2015-2020)

Figure Europe Fragment-Based Drug Discovery Revenue (USD ) Growth (2015-2020)

Table Europe Fragment-Based Drug Discovery Sales by Countries (2015-2020)

Table Europe Fragment-Based Drug Discovery Sales Market Share by Countries (2015-2020)

Figure Europe Fragment-Based Drug Discovery Sales Market Share by Countries in 2015

Figure Europe Fragment-Based Drug Discovery Sales Market Share by Countries in 2019

Table Europe Fragment-Based Drug Discovery Revenue (USD ) by Countries (2015-2020)

Table Europe Fragment-Based Drug Discovery Revenue Market Share by Countries (2015-2020)

Figure Europe Fragment-Based Drug Discovery Revenue Market Share by Countries in 2015

Figure Europe Fragment-Based Drug Discovery Revenue Market Share by Countries in 2019

Figure Germany Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure UK Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure France Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Italy Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Spain Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Russia Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Fragment-Based Drug Discovery Revenue (USD ) and Growth (2015-2020)

Table Asia-Pacific Fragment-Based Drug Discovery Sales by Countries (2015-2020)

Table Asia-Pacific Fragment-Based Drug Discovery Sales Market Share by Countries (2015-2020)

Figure Asia-Pacific Fragment-Based Drug Discovery Sales Market Share by Countries in 2015

Figure Asia-Pacific Fragment-Based Drug Discovery Sales Market Share by Countries in 2019

Table Asia-Pacific Fragment-Based Drug Discovery Revenue (USD ) by Countries (2015-2020)

Table Asia-Pacific Fragment-Based Drug Discovery Revenue Market Share by Countries (2015-2020)

Figure Asia-Pacific Fragment-Based Drug Discovery Revenue Market Share by Countries in 2015

Figure Asia-Pacific Fragment-Based Drug Discovery Revenue Market Share by Countries in 2019

Figure China Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Japan Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure South Korea Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Australia Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure India Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Southeast Asia Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Fragment-Based Drug Discovery Revenue (USD ) and Growth (2015-2020)

Table Middle East and Africa Fragment-Based Drug Discovery Sales by Countries (2015-2020)

Table Middle East and Africa Fragment-Based Drug Discovery Sales Market Share by Countries (2015-2020)

Table Middle East and Africa Fragment-Based Drug Discovery Revenue (USD ) by Countries (2015-2020)

Table Middle East and Africa Fragment-Based Drug Discovery Revenue Market Share by Countries (2015-2020)

Figure Middle East and Africa Fragment-Based Drug Discovery Revenue Market Share by Countries in 2015

Figure Middle East and Africa Fragment-Based Drug Discovery Revenue Market Share by Countries in 2019

Figure Saudi Arabia Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure UAE Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Egypt Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Nigeria Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure South Africa Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure South America Fragment-Based Drug Discovery Revenue (USD ) and Growth (2015-2020)

Table South America Fragment-Based Drug Discovery Sales by Countries (2015-2020)

Table South America Fragment-Based Drug Discovery Sales Market Share by Countries (2015-2020)

Table South America Fragment-Based Drug Discovery Revenue (USD ) by Countries (2015-2020)

Table South America Fragment-Based Drug Discovery Revenue Market Share by Countries (2015-2020)

Figure South America Fragment-Based Drug Discovery Revenue Market Share by Countries in 2015

Figure South America Fragment-Based Drug Discovery Revenue Market Share by Countries in 2019

Figure Brazil Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Argentina Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Columbia Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Chile Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Table Global Fragment-Based Drug Discovery Sales by Types (2015-2020)

Table Global Fragment-Based Drug Discovery Sales Share by Types (2015-2020)

Table Global Fragment-Based Drug Discovery Revenue (USD ) by Types (2015-2020)

Table Global Fragment-Based Drug Discovery Revenue Share by Types (2015-2020)

Figure Global NMR Spectroscopy Sales and Growth Rate (2015-2020)

Figure Global NMR Spectroscopy Price (2015-2020)

Figure Global DSF Assay Sales and Growth Rate (2015-2020)

Figure Global DSF Assay Price (2015-2020)

Figure Global Fluorescence Polarization (FP) Sales and Growth Rate (2015-2020)

Figure Global Fluorescence Polarization (FP) Price (2015-2020)

Figure Global Isothermal Titration Calorimetry (ITC) Sales and Growth Rate (2015-2020)

Figure Global Isothermal Titration Calorimetry (ITC) Price (2015-2020)

Figure Global X-ray Crystallography Sales and Growth Rate (2015-2020)

Figure Global X-ray Crystallography Price (2015-2020)

Table Global Fragment-Based Drug Discovery Sales by Applications (2015-2020)

Table Global Fragment-Based Drug Discovery Sales Share by Applications (2015-2020)

Figure Global Biopharmaceutical Companies Sales and Growth Rate (2015-2020)

Figure Global Biopharmaceutical Companies Revenue and Growth Rate (2015-2020)

Figure Global CROs Sales and Growth Rate (2015-2020)

Figure Global CROs Revenue and Growth Rate (2015-2020)

Figure Global Academic and Research Institutions Sales and Growth Rate (2015-2020)

Figure Global Academic and Research Institutions Revenue and Growth Rate (2015-2020)

Figure Global Fragment-Based Drug Discovery Sales and Growth Rate (2020-2026)

Figure Global Fragment-Based Drug Discovery Revenue (USD ) and Growth Rate (2020-2026)

Table Global Fragment-Based Drug Discovery Sales Forecast by Regions (2020-2026)

Table Global Fragment-Based Drug Discovery Revenue Forecast by Regions (2020-2026)

Figure North America Fragment-Based Drug Discovery Sales Forecast (2020-2026)

Figure North America Fragment-Based Drug Discovery Revenue Forecast (2020-2026)

Figure Europe Fragment-Based Drug Discovery Sales Forecast (2020-2026)

Figure Europe Fragment-Based Drug Discovery Revenue Forecast (2020-2026)

Figure Asia-Pacific Fragment-Based Drug Discovery Sales Forecast (2020-2026)

Figure Asia-Pacific Fragment-Based Drug Discovery Revenue Forecast (2020-2026)

Figure Middle East and Africa Fragment-Based Drug Discovery Sales Forecast (2020-2026)

Figure Middle East and Africa Fragment-Based Drug Discovery Revenue Forecast (2020-2026)

Figure South America Fragment-Based Drug Discovery Sales Forecast (2020-2026)

Figure South America Fragment-Based Drug Discovery Revenue Forecast (2020-2026)

Table Global Fragment-Based Drug Discovery Sales Forecast by Types (2020-2026)

Table Global Fragment-Based Drug Discovery Sales Market Share Forecast by Types (2020-2026)

Table Global Fragment-Based Drug Discovery Revenue Forecast by Types (2020-2026)

Table Global Fragment-Based Drug Discovery Revenue Market Share Forecast by Types (2020-2026)

Table Global Fragment-Based Drug Discovery Sales Forecast by Applications (2020-2026)

Table Global Fragment-Based Drug Discovery Sales Market Share Forecast by Applications (2020-2026)

Table Global Fragment-Based Drug Discovery Revenue Forecast by Applications (2020-2026)

Table Global Fragment-Based Drug Discovery Revenue Market Share Forecast by Applications (2020-2026)

Licence Rights

Single User License:

1. The Single User License allows for the use of a report by a single user within one corporate location.

2. The report paper copy may not be reproduced .

3. Report PDF copy cannot be copied (if purchased) and must remain on one computer.

4. Only a single copy of the publication may be printed for internal use.

5.  Users may include information in the report in presentations and internal reports by providing full copyright credit to Maia Research.

6.   Users may not share the report (or any information contained therein) with any other person or persons outside the corporate location for which the report is purchased.

 

Enterprise License:

1. The Enterprise License allows for the use of a report by unlimited users within the purchasing organization.

2. Purchasing organization shall have the right to share the report with third parties. (investors, consultants, etc.) from time to time under the global license agreement, provided that such third parties have a confidentiality agreement with the purchasing organization and agree to be bound by the terms of the global license agreement.

3. Employees of the purchasing organization can include information given in the report in presentations and internal reports by providing full copyright credit to Maia Research.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

The Fragment-Based Drug Discovery market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Fragment-Based Drug Discovery market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Fragment-Based Drug Discovery market. The report focuses on well-known providers in the global Fragment-Based Drug Discovery industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Fragment-Based Drug Discovery Industry will develop is also analyzed in detail in Chapter 1.7 of the report.

In Chapter 2.4, we analyzed industry trends in the context of COVID-19.

In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.

In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.

In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Fragment-Based Drug Discovery market covered in Chapter 4:

Sygnature Discovery

Crown Bioscience, Inc

Alveus Pharmaceuticals Pvt. Ltd

Proteros Fragments GmbH

Emerald BioStructures, Inc

Structure Based Design, Inc

Charles River Laboratories International, Inc

Evotec AG

Sprint Bioscience

Kinetic Discovery Limited

Astex Pharmaceuticals

Beactica AB

In Chapter 11 and 13.3, on the basis of types, the Fragment-Based Drug Discovery market from 2015 to 2026 is primarily split into:

NMR Spectroscopy

DSF Assay

Fluorescence Polarization (FP)

Isothermal Titration Calorimetry (ITC)

X-ray Crystallography

In Chapter 12 and 13.4, on the basis of applications, the Fragment-Based Drug Discovery market from 2015 to 2026 covers:

Biopharmaceutical Companies

CROs

Academic and Research Institutions

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:

North America (Covered in Chapter 6 and 13)

United States

Canada

Mexico

Europe (Covered in Chapter 7 and 13)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 8 and 13)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 9 and 13)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 10 and 13)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2026

READ MORE

Scope

Table of Content

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Regulatory Scenario by Region/Country

1.4 Market Investment Scenario Strategic

1.5 Market Analysis by Type

1.5.1 Global Fragment-Based Drug Discovery Market Share by Type (2020-2026)

1.5.2 NMR Spectroscopy

1.5.3 DSF Assay

1.5.4 Fluorescence Polarization (FP)

1.5.5 Isothermal Titration Calorimetry (ITC)

1.5.6 X-ray Crystallography

1.6 Market by Application

1.6.1 Global Fragment-Based Drug Discovery Market Share by Application (2020-2026)

1.6.2 Biopharmaceutical Companies

1.6.3 CROs

1.6.4 Academic and Research Institutions

1.7 Fragment-Based Drug Discovery Industry Development Trends under COVID-19 Outbreak

1.7.1 Global COVID-19 Status Overview

1.7.2 Influence of COVID-19 Outbreak on Fragment-Based Drug Discovery Industry Development

2. Global Market Growth Trends

2.1 Industry Trends

2.1.1 SWOT Analysis

2.1.2 PorteraEURs Five Forces Analysis

2.2 Potential Market and Growth Potential Analysis

2.3 Industry News and Policies by Regions

2.3.1 Industry News

2.3.2 Industry Policies

2.4 Industry Trends Under COVID-19

3 Value Chain of Fragment-Based Drug Discovery Market

3.1 Value Chain Status

3.2 Fragment-Based Drug Discovery Manufacturing Cost Structure Analysis

3.2.1 Production Process Analysis

3.2.2 Manufacturing Cost Structure of Fragment-Based Drug Discovery

3.2.3 Labor Cost of Fragment-Based Drug Discovery

3.2.3.1 Labor Cost of Fragment-Based Drug Discovery Under COVID-19

3.3 Sales and Marketing Model Analysis

3.4 Downstream Major Customer Analysis (by Region)

3.5 Value Chain Status Under COVID-19

4 Players Profiles

4.1 Sygnature Discovery

4.1.1 Sygnature Discovery Basic Information

4.1.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification

4.1.3 Sygnature Discovery Fragment-Based Drug Discovery Market Performance (2015-2020)

4.1.4 Sygnature Discovery Business Overview

4.2 Crown Bioscience, Inc

4.2.1 Crown Bioscience, Inc Basic Information

4.2.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification

4.2.3 Crown Bioscience, Inc Fragment-Based Drug Discovery Market Performance (2015-2020)

4.2.4 Crown Bioscience, Inc Business Overview

4.3 Alveus Pharmaceuticals Pvt. Ltd

4.3.1 Alveus Pharmaceuticals Pvt. Ltd Basic Information

4.3.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification

4.3.3 Alveus Pharmaceuticals Pvt. Ltd Fragment-Based Drug Discovery Market Performance (2015-2020)

4.3.4 Alveus Pharmaceuticals Pvt. Ltd Business Overview

4.4 Proteros Fragments GmbH

4.4.1 Proteros Fragments GmbH Basic Information

4.4.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification

4.4.3 Proteros Fragments GmbH Fragment-Based Drug Discovery Market Performance (2015-2020)

4.4.4 Proteros Fragments GmbH Business Overview

4.5 Emerald BioStructures, Inc

4.5.1 Emerald BioStructures, Inc Basic Information

4.5.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification

4.5.3 Emerald BioStructures, Inc Fragment-Based Drug Discovery Market Performance (2015-2020)

4.5.4 Emerald BioStructures, Inc Business Overview

4.6 Structure Based Design, Inc

4.6.1 Structure Based Design, Inc Basic Information

4.6.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification

4.6.3 Structure Based Design, Inc Fragment-Based Drug Discovery Market Performance (2015-2020)

4.6.4 Structure Based Design, Inc Business Overview

4.7 Charles River Laboratories International, Inc

4.7.1 Charles River Laboratories International, Inc Basic Information

4.7.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification

4.7.3 Charles River Laboratories International, Inc Fragment-Based Drug Discovery Market Performance (2015-2020)

4.7.4 Charles River Laboratories International, Inc Business Overview

4.8 Evotec AG

4.8.1 Evotec AG Basic Information

4.8.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification

4.8.3 Evotec AG Fragment-Based Drug Discovery Market Performance (2015-2020)

4.8.4 Evotec AG Business Overview

4.9 Sprint Bioscience

4.9.1 Sprint Bioscience Basic Information

4.9.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification

4.9.3 Sprint Bioscience Fragment-Based Drug Discovery Market Performance (2015-2020)

4.9.4 Sprint Bioscience Business Overview

4.10 Kinetic Discovery Limited

4.10.1 Kinetic Discovery Limited Basic Information

4.10.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification

4.10.3 Kinetic Discovery Limited Fragment-Based Drug Discovery Market Performance (2015-2020)

4.10.4 Kinetic Discovery Limited Business Overview

4.11 Astex Pharmaceuticals

4.11.1 Astex Pharmaceuticals Basic Information

4.11.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification

4.11.3 Astex Pharmaceuticals Fragment-Based Drug Discovery Market Performance (2015-2020)

4.11.4 Astex Pharmaceuticals Business Overview

4.12 Beactica AB

4.12.1 Beactica AB Basic Information

4.12.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification

4.12.3 Beactica AB Fragment-Based Drug Discovery Market Performance (2015-2020)

4.12.4 Beactica AB Business Overview

5 Global Fragment-Based Drug Discovery Market Analysis by Regions

5.1 Global Fragment-Based Drug Discovery Sales, Revenue and Market Share by Regions

5.1.1 Global Fragment-Based Drug Discovery Sales by Regions (2015-2020)

5.1.2 Global Fragment-Based Drug Discovery Revenue by Regions (2015-2020)

5.2 North America Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

5.3 Europe Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

5.4 Asia-Pacific Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

5.5 Middle East and Africa Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

5.6 South America Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

6 North America Fragment-Based Drug Discovery Market Analysis by Countries

6.1 North America Fragment-Based Drug Discovery Sales, Revenue and Market Share by Countries

6.1.1 North America Fragment-Based Drug Discovery Sales by Countries (2015-2020)

6.1.2 North America Fragment-Based Drug Discovery Revenue by Countries (2015-2020)

6.1.3 North America Fragment-Based Drug Discovery Market Under COVID-19

6.2 United States Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

6.2.1 United States Fragment-Based Drug Discovery Market Under COVID-19

6.3 Canada Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

6.4 Mexico Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

7 Europe Fragment-Based Drug Discovery Market Analysis by Countries

7.1 Europe Fragment-Based Drug Discovery Sales, Revenue and Market Share by Countries

7.1.1 Europe Fragment-Based Drug Discovery Sales by Countries (2015-2020)

7.1.2 Europe Fragment-Based Drug Discovery Revenue by Countries (2015-2020)

7.1.3 Europe Fragment-Based Drug Discovery Market Under COVID-19

7.2 Germany Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

7.2.1 Germany Fragment-Based Drug Discovery Market Under COVID-19

7.3 UK Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

7.3.1 UK Fragment-Based Drug Discovery Market Under COVID-19

7.4 France Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

7.4.1 France Fragment-Based Drug Discovery Market Under COVID-19

7.5 Italy Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

7.5.1 Italy Fragment-Based Drug Discovery Market Under COVID-19

7.6 Spain Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

7.6.1 Spain Fragment-Based Drug Discovery Market Under COVID-19

7.7 Russia Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

7.7.1 Russia Fragment-Based Drug Discovery Market Under COVID-19

8 Asia-Pacific Fragment-Based Drug Discovery Market Analysis by Countries

8.1 Asia-Pacific Fragment-Based Drug Discovery Sales, Revenue and Market Share by Countries

8.1.1 Asia-Pacific Fragment-Based Drug Discovery Sales by Countries (2015-2020)

8.1.2 Asia-Pacific Fragment-Based Drug Discovery Revenue by Countries (2015-2020)

8.1.3 Asia-Pacific Fragment-Based Drug Discovery Market Under COVID-19

8.2 China Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

8.2.1 China Fragment-Based Drug Discovery Market Under COVID-19

8.3 Japan Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

8.3.1 Japan Fragment-Based Drug Discovery Market Under COVID-19

8.4 South Korea Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

8.4.1 South Korea Fragment-Based Drug Discovery Market Under COVID-19

8.5 Australia Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

8.6 India Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

8.6.1 India Fragment-Based Drug Discovery Market Under COVID-19

8.7 Southeast Asia Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

8.7.1 Southeast Asia Fragment-Based Drug Discovery Market Under COVID-19

9 Middle East and Africa Fragment-Based Drug Discovery Market Analysis by Countries

9.1 Middle East and Africa Fragment-Based Drug Discovery Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Fragment-Based Drug Discovery Sales by Countries (2015-2020)

9.1.2 Middle East and Africa Fragment-Based Drug Discovery Revenue by Countries (2015-2020)

9.1.3 Middle East and Africa Fragment-Based Drug Discovery Market Under COVID-19

9.2 Saudi Arabia Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

9.3 UAE Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

9.4 Egypt Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

9.5 Nigeria Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

9.6 South Africa Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

10 South America Fragment-Based Drug Discovery Market Analysis by Countries

10.1 South America Fragment-Based Drug Discovery Sales, Revenue and Market Share by Countries

10.1.1 South America Fragment-Based Drug Discovery Sales by Countries (2015-2020)

10.1.2 South America Fragment-Based Drug Discovery Revenue by Countries (2015-2020)

10.1.3 South America Fragment-Based Drug Discovery Market Under COVID-19

10.2 Brazil Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

10.2.1 Brazil Fragment-Based Drug Discovery Market Under COVID-19

10.3 Argentina Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

10.4 Columbia Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

10.5 Chile Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

11 Global Fragment-Based Drug Discovery Market Segment by Types

11.1 Global Fragment-Based Drug Discovery Sales, Revenue and Market Share by Types (2015-2020)

11.1.1 Global Fragment-Based Drug Discovery Sales and Market Share by Types (2015-2020)

11.1.2 Global Fragment-Based Drug Discovery Revenue and Market Share by Types (2015-2020)

11.2 NMR Spectroscopy Sales and Price (2015-2020)

11.3 DSF Assay Sales and Price (2015-2020)

11.4 Fluorescence Polarization (FP) Sales and Price (2015-2020)

11.5 Isothermal Titration Calorimetry (ITC) Sales and Price (2015-2020)

11.6 X-ray Crystallography Sales and Price (2015-2020)

12 Global Fragment-Based Drug Discovery Market Segment by Applications

12.1 Global Fragment-Based Drug Discovery Sales, Revenue and Market Share by Applications (2015-2020)

12.1.1 Global Fragment-Based Drug Discovery Sales and Market Share by Applications (2015-2020)

12.1.2 Global Fragment-Based Drug Discovery Revenue and Market Share by Applications (2015-2020)

12.2 Biopharmaceutical Companies Sales, Revenue and Growth Rate (2015-2020)

12.3 CROs Sales, Revenue and Growth Rate (2015-2020)

12.4 Academic and Research Institutions Sales, Revenue and Growth Rate (2015-2020)

13 Fragment-Based Drug Discovery Market Forecast by Regions (2020-2026)

13.1 Global Fragment-Based Drug Discovery Sales, Revenue and Growth Rate (2020-2026)

13.2 Fragment-Based Drug Discovery Market Forecast by Regions (2020-2026)

13.2.1 North America Fragment-Based Drug Discovery Market Forecast (2020-2026)

13.2.2 Europe Fragment-Based Drug Discovery Market Forecast (2020-2026)

13.2.3 Asia-Pacific Fragment-Based Drug Discovery Market Forecast (2020-2026)

13.2.4 Middle East and Africa Fragment-Based Drug Discovery Market Forecast (2020-2026)

13.2.5 South America Fragment-Based Drug Discovery Market Forecast (2020-2026)

13.3 Fragment-Based Drug Discovery Market Forecast by Types (2020-2026)

13.4 Fragment-Based Drug Discovery Market Forecast by Applications (2020-2026)

13.5 Fragment-Based Drug Discovery Market Forecast Under COVID-19

14 Appendix

14.1 Methodology

14.2 Research Data Source


List Of Figure

List of Tables and Figures

Table Global Fragment-Based Drug Discovery Market Size Growth Rate by Type (2020-2026)

Figure Global Fragment-Based Drug Discovery Market Share by Type in 2019 & 2026

Figure NMR Spectroscopy Features

Figure DSF Assay Features

Figure Fluorescence Polarization (FP) Features

Figure Isothermal Titration Calorimetry (ITC) Features

Figure X-ray Crystallography Features

Table Global Fragment-Based Drug Discovery Market Size Growth by Application (2020-2026)

Figure Global Fragment-Based Drug Discovery Market Share by Application in 2019 & 2026

Figure Biopharmaceutical Companies Description

Figure CROs Description

Figure Academic and Research Institutions Description

Figure Global COVID-19 Status Overview

Table Influence of COVID-19 Outbreak on Fragment-Based Drug Discovery Industry Development

Table SWOT Analysis

Figure Porter's Five Forces Analysis

Figure Global Fragment-Based Drug Discovery Market Size and Growth Rate 2015-2026

Table Industry News

Table Industry Policies

Figure Value Chain Status of Fragment-Based Drug Discovery

Figure Production Process of Fragment-Based Drug Discovery

Figure Manufacturing Cost Structure of Fragment-Based Drug Discovery

Figure Major Company Analysis (by Business Distribution Base, by Product Type)

Table Downstream Major Customer Analysis (by Region)

Table Sygnature Discovery Profile

Table Sygnature Discovery Production, Value, Price, Gross Margin 2015-2020

Table Crown Bioscience, Inc Profile

Table Crown Bioscience, Inc Production, Value, Price, Gross Margin 2015-2020

Table Alveus Pharmaceuticals Pvt. Ltd Profile

Table Alveus Pharmaceuticals Pvt. Ltd Production, Value, Price, Gross Margin 2015-2020

Table Proteros Fragments GmbH Profile

Table Proteros Fragments GmbH Production, Value, Price, Gross Margin 2015-2020

Table Emerald BioStructures, Inc Profile

Table Emerald BioStructures, Inc Production, Value, Price, Gross Margin 2015-2020

Table Structure Based Design, Inc Profile

Table Structure Based Design, Inc Production, Value, Price, Gross Margin 2015-2020

Table Charles River Laboratories International, Inc Profile

Table Charles River Laboratories International, Inc Production, Value, Price, Gross Margin 2015-2020

Table Evotec AG Profile

Table Evotec AG Production, Value, Price, Gross Margin 2015-2020

Table Sprint Bioscience Profile

Table Sprint Bioscience Production, Value, Price, Gross Margin 2015-2020

Table Kinetic Discovery Limited Profile

Table Kinetic Discovery Limited Production, Value, Price, Gross Margin 2015-2020

Table Astex Pharmaceuticals Profile

Table Astex Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020

Table Beactica AB Profile

Table Beactica AB Production, Value, Price, Gross Margin 2015-2020

Figure Global Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Global Fragment-Based Drug Discovery Revenue (USD ) and Growth (2015-2020)

Table Global Fragment-Based Drug Discovery Sales by Regions (2015-2020)

Table Global Fragment-Based Drug Discovery Sales Market Share by Regions (2015-2020)

Table Global Fragment-Based Drug Discovery Revenue (USD ) by Regions (2015-2020)

Table Global Fragment-Based Drug Discovery Revenue Market Share by Regions (2015-2020)

Table Global Fragment-Based Drug Discovery Revenue Market Share by Regions in 2015

Table Global Fragment-Based Drug Discovery Revenue Market Share by Regions in 2019

Figure North America Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Europe Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure South America Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure North America Fragment-Based Drug Discovery Revenue (USD ) and Growth (2015-2020)

Table North America Fragment-Based Drug Discovery Sales by Countries (2015-2020)

Table North America Fragment-Based Drug Discovery Sales Market Share by Countries (2015-2020)

Figure North America Fragment-Based Drug Discovery Sales Market Share by Countries in 2015

Figure North America Fragment-Based Drug Discovery Sales Market Share by Countries in 2019

Table North America Fragment-Based Drug Discovery Revenue (USD ) by Countries (2015-2020)

Table North America Fragment-Based Drug Discovery Revenue Market Share by Countries (2015-2020)

Figure North America Fragment-Based Drug Discovery Revenue Market Share by Countries in 2015

Figure North America Fragment-Based Drug Discovery Revenue Market Share by Countries in 2019

Figure United States Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Canada Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Mexico Fragment-Based Drug Discovery Sales and Growth (2015-2020)

Figure Europe Fragment-Based Drug Discovery Revenue (USD ) Growth (2015-2020)

Table Europe Fragment-Based Drug Discovery Sales by Countries (2015-2020)

Table Europe Fragment-Based Drug Discovery Sales Market Share by Countries (2015-2020)

Figure Europe Fragment-Based Drug Discovery Sales Market Share by Countries in 2015

Figure Europe Fragment-Based Drug Discovery Sales Market Share by Countries in 2019

Table Europe Fragment-Based Drug Discovery Revenue (USD ) by Countries (2015-2020)

Table Europe Fragment-Based Drug Discovery Revenue Market Share by Countries (2015-2020)

Figure Europe Fragment-Based Drug Discovery Revenue Market Share by Countries in 2015

Figure Europe Fragment-Based Drug Discovery Revenue Market Share by Countries in 2019

Figure Germany Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure UK Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure France Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Italy Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Spain Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Russia Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Fragment-Based Drug Discovery Revenue (USD ) and Growth (2015-2020)

Table Asia-Pacific Fragment-Based Drug Discovery Sales by Countries (2015-2020)

Table Asia-Pacific Fragment-Based Drug Discovery Sales Market Share by Countries (2015-2020)

Figure Asia-Pacific Fragment-Based Drug Discovery Sales Market Share by Countries in 2015

Figure Asia-Pacific Fragment-Based Drug Discovery Sales Market Share by Countries in 2019

Table Asia-Pacific Fragment-Based Drug Discovery Revenue (USD ) by Countries (2015-2020)

Table Asia-Pacific Fragment-Based Drug Discovery Revenue Market Share by Countries (2015-2020)

Figure Asia-Pacific Fragment-Based Drug Discovery Revenue Market Share by Countries in 2015

Figure Asia-Pacific Fragment-Based Drug Discovery Revenue Market Share by Countries in 2019

Figure China Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Japan Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure South Korea Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Australia Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure India Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Southeast Asia Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Fragment-Based Drug Discovery Revenue (USD ) and Growth (2015-2020)

Table Middle East and Africa Fragment-Based Drug Discovery Sales by Countries (2015-2020)

Table Middle East and Africa Fragment-Based Drug Discovery Sales Market Share by Countries (2015-2020)

Table Middle East and Africa Fragment-Based Drug Discovery Revenue (USD ) by Countries (2015-2020)

Table Middle East and Africa Fragment-Based Drug Discovery Revenue Market Share by Countries (2015-2020)

Figure Middle East and Africa Fragment-Based Drug Discovery Revenue Market Share by Countries in 2015

Figure Middle East and Africa Fragment-Based Drug Discovery Revenue Market Share by Countries in 2019

Figure Saudi Arabia Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure UAE Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Egypt Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Nigeria Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure South Africa Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure South America Fragment-Based Drug Discovery Revenue (USD ) and Growth (2015-2020)

Table South America Fragment-Based Drug Discovery Sales by Countries (2015-2020)

Table South America Fragment-Based Drug Discovery Sales Market Share by Countries (2015-2020)

Table South America Fragment-Based Drug Discovery Revenue (USD ) by Countries (2015-2020)

Table South America Fragment-Based Drug Discovery Revenue Market Share by Countries (2015-2020)

Figure South America Fragment-Based Drug Discovery Revenue Market Share by Countries in 2015

Figure South America Fragment-Based Drug Discovery Revenue Market Share by Countries in 2019

Figure Brazil Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Argentina Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Columbia Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Figure Chile Fragment-Based Drug Discovery Sales and Growth Rate (2015-2020)

Table Global Fragment-Based Drug Discovery Sales by Types (2015-2020)

Table Global Fragment-Based Drug Discovery Sales Share by Types (2015-2020)

Table Global Fragment-Based Drug Discovery Revenue (USD ) by Types (2015-2020)

Table Global Fragment-Based Drug Discovery Revenue Share by Types (2015-2020)

Figure Global NMR Spectroscopy Sales and Growth Rate (2015-2020)

Figure Global NMR Spectroscopy Price (2015-2020)

Figure Global DSF Assay Sales and Growth Rate (2015-2020)

Figure Global DSF Assay Price (2015-2020)

Figure Global Fluorescence Polarization (FP) Sales and Growth Rate (2015-2020)

Figure Global Fluorescence Polarization (FP) Price (2015-2020)

Figure Global Isothermal Titration Calorimetry (ITC) Sales and Growth Rate (2015-2020)

Figure Global Isothermal Titration Calorimetry (ITC) Price (2015-2020)

Figure Global X-ray Crystallography Sales and Growth Rate (2015-2020)

Figure Global X-ray Crystallography Price (2015-2020)

Table Global Fragment-Based Drug Discovery Sales by Applications (2015-2020)

Table Global Fragment-Based Drug Discovery Sales Share by Applications (2015-2020)

Figure Global Biopharmaceutical Companies Sales and Growth Rate (2015-2020)

Figure Global Biopharmaceutical Companies Revenue and Growth Rate (2015-2020)

Figure Global CROs Sales and Growth Rate (2015-2020)

Figure Global CROs Revenue and Growth Rate (2015-2020)

Figure Global Academic and Research Institutions Sales and Growth Rate (2015-2020)

Figure Global Academic and Research Institutions Revenue and Growth Rate (2015-2020)

Figure Global Fragment-Based Drug Discovery Sales and Growth Rate (2020-2026)

Figure Global Fragment-Based Drug Discovery Revenue (USD ) and Growth Rate (2020-2026)

Table Global Fragment-Based Drug Discovery Sales Forecast by Regions (2020-2026)

Table Global Fragment-Based Drug Discovery Revenue Forecast by Regions (2020-2026)

Figure North America Fragment-Based Drug Discovery Sales Forecast (2020-2026)

Figure North America Fragment-Based Drug Discovery Revenue Forecast (2020-2026)

Figure Europe Fragment-Based Drug Discovery Sales Forecast (2020-2026)

Figure Europe Fragment-Based Drug Discovery Revenue Forecast (2020-2026)

Figure Asia-Pacific Fragment-Based Drug Discovery Sales Forecast (2020-2026)

Figure Asia-Pacific Fragment-Based Drug Discovery Revenue Forecast (2020-2026)

Figure Middle East and Africa Fragment-Based Drug Discovery Sales Forecast (2020-2026)

Figure Middle East and Africa Fragment-Based Drug Discovery Revenue Forecast (2020-2026)

Figure South America Fragment-Based Drug Discovery Sales Forecast (2020-2026)

Figure South America Fragment-Based Drug Discovery Revenue Forecast (2020-2026)

Table Global Fragment-Based Drug Discovery Sales Forecast by Types (2020-2026)

Table Global Fragment-Based Drug Discovery Sales Market Share Forecast by Types (2020-2026)

Table Global Fragment-Based Drug Discovery Revenue Forecast by Types (2020-2026)

Table Global Fragment-Based Drug Discovery Revenue Market Share Forecast by Types (2020-2026)

Table Global Fragment-Based Drug Discovery Sales Forecast by Applications (2020-2026)

Table Global Fragment-Based Drug Discovery Sales Market Share Forecast by Applications (2020-2026)

Table Global Fragment-Based Drug Discovery Revenue Forecast by Applications (2020-2026)

Table Global Fragment-Based Drug Discovery Revenue Market Share Forecast by Applications (2020-2026)

Single User License:

1. The Single User License allows for the use of a report by a single user within one corporate location.

2. The report paper copy may not be reproduced .

3. Report PDF copy cannot be copied (if purchased) and must remain on one computer.

4. Only a single copy of the publication may be printed for internal use.

5.  Users may include information in the report in presentations and internal reports by providing full copyright credit to Maia Research.

6.   Users may not share the report (or any information contained therein) with any other person or persons outside the corporate location for which the report is purchased.

 

Enterprise License:

1. The Enterprise License allows for the use of a report by unlimited users within the purchasing organization.

2. Purchasing organization shall have the right to share the report with third parties. (investors, consultants, etc.) from time to time under the global license agreement, provided that such third parties have a confidentiality agreement with the purchasing organization and agree to be bound by the terms of the global license agreement.

3. Employees of the purchasing organization can include information given in the report in presentations and internal reports by providing full copyright credit to Maia Research.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS